Trial Profile

Comparing the Efficacy and Safety of Three Dose Regimens of BioChaperone PDGF-BB to Becaplermin Gel For the Treatment of Diabetic Foot Ulcer

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 08 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Becaplermin (Primary) ; Becaplermin
Indications Diabetic foot ulcer
Focus Therapeutic Use
Sponsors Adocia; Virchow Group

Most Recent Events

26 Apr 2012 Results will be presented at the European Wound Management Association in May 2012 and the World Union of Wound Healing Societies in September 2012.
28 Feb 2012 The trial enrolled 198 patients, according to an Adocia media release.
28 Feb 2012 Status changed from recruiting to completed, according to an Adocia media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com